Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders

JAMA Neurology

Volumn 72, Issue 1, 2015, Pages 81-87

  Flanagan, Eoin P ^a   Weinshenker, Brian G ^a   Krecke, Karl N ^a   Lennon, Vanda A ^a,b   Lucchinetti, Claudia F ^a   McKeon, Andrew ^a   Wingerchuk, Dean M ^c   Shuster, Elizabeth A ^d   Jiao, Yujuan ^a   Horta, Erika S ^a   Pittock, Sean J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEMYELINATING DISEASE; DISEASE DURATION; ETHNICITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; MUSCLE SPASM; MYELITIS; MYELOOPTIC NEUROPATHY; NAUSEA; NEUROMYELITIS OPTICA SPECTRUM DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; POPULATION RESEARCH; PROTEIN ANALYSIS; RACE; SHORT MYELITIS LESION; SPINE RADIOGRAPHY; VOMITING; BLOOD; COMPLICATION; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; SPINAL CORD;

ADULT; AGED; AQUAPORIN 4; FEMALE; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS; NEUROMYELITIS OPTICA; SPINAL CORD; STATISTICS, NONPARAMETRIC;

EID: 84921057087     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.2137     Document Type: Article

References (21)

1. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
2. Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008;70(5):344-352.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112.
4. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-569.
5. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
6. Jiao Y, Fryer JP, Lennon VA, et al. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014;71(1):48-54.
7. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
8. Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol. 2006;63(10):1398-1400.
9. Ortega MR, Tornes L, Rammohan KW. NMO spectrum presenting as partial myelitis. Mult Scler. 2013;19(2):252-253.
10. Chan KH, Ramsden DB, Yu YL, et al. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol. 2009;16(3):310-316.
11. Asgari N, Skejoe HP, Lennon VA. Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient. Neurology. 2013;81(1):95-96.
12. Siritho S, Nakashima I, Takahashi T, Fujihara K, Prayoonwiwat N. AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology. 2011;77(9):827-834.
13. Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology. 2013;80(24):2210-2216.
14. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59(4):499-505.
15. Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler. 2012;18(10):1480-1483.
16. Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol. 2012;69(9):1176-1180.
17. Kim SM, Go MJ, Sung JJ, Park KS, Lee KW. Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. Arch Neurol. 2012;69(8):1026-1031.
18. Asgari N, Skejoe HP, Lillevang ST, Steenstrup T, Stenager E, Kyvik KO. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study. BMC Neurol. 2013;13:33.
19. Waters PJ, McKeon A, Leite MI, et al. Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology. 2012;78(9):665-671, discussion 669.
20. Pittock SJ, Lennon VA, Bakshi N, et al. Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis. JAMA Neurol. 2014.
21. Collongues N, Cabre P, Marignier R, et al; Group Members for NOMADMUS and CF-SEP. A benign form of neuromyelitis optica: does it exist? Arch Neurol. 2011;68(7):918-924.